Skip to main content
. 2020 Mar 25;91(5):512–519. doi: 10.1136/jnnp-2019-322702

Figure 1.

Figure 1

The consensus framework for the management of visual hallucinations in different conditions. Recommendations not supported by meta-analysis are indicated in white. Orange boxes indicate hallucination characteristics and therapeutic targets.AD, Alzheimer’s disease; CBS, Charles Bonnet syndrome; CBT, cognitive behavioural therapy; DLB, dementia with Lewy bodies;PD, Parkinson’s disease; PDD, PD dementia.